BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND MUC1, PEM, 4582, ENSG00000185499, PUM, MAM6, EMA, CD227, H23AG AND Prognosis
133 results:

  • 1. Methylthioadenosine Phosphorylase and breast cancer 1 Protein-Associated Protein 1 as Biomarkers for the Peritoneal Mesothelioma.
    Chen Y; Du X; Gao Y; Wu H; Zhao H; Su Y
    Cancer Control; 2023; 30():10732748231220805. PubMed ID: 38092371
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Single Cell Phenotypic Analysis for cancer Stem Cell Identification by Dual-Isotope ICP-QMS.
    Liu M; Wei X; Wu C; Liu J; Wei Y; Wang X; Chen ML; Yang T; Wang JH
    Anal Chem; 2023 Sep; 95(38):14447-14454. PubMed ID: 37695163
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Updated Clinical Perspectives and Challenges of Chimeric Antigen Receptor-T Cell Therapy in Colorectal cancer and Invasive breast cancer.
    Cao Y; Efetov SK; He M; Fu Y; Beeraka NM; Zhang J; Zhang X; Bannimath N; Chen K
    Arch Immunol Ther Exp (Warsz); 2023 Aug; 71(1):19. PubMed ID: 37566162
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Targeting KK-LC-1 inhibits malignant biological behaviors of triple-negative breast cancer.
    Zhu X; Bu J; Zhu T; Jiang Y
    J Transl Med; 2023 Mar; 21(1):184. PubMed ID: 36895039
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A case of extensively spreading acinic cell carcinoma of the breast with microglandular features.
    Sugino T; Kakuda Y; Yasui H; Oishi T; Norose T; Kawata T; Tadokoro Y; Nishimura S
    Pathol Int; 2023 Jan; 73(1):45-51. PubMed ID: 36579416
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A phase I study of an adenoviral vector delivering a muc1/CD40-ligand fusion protein in patients with advanced adenocarcinoma.
    Tan TJ; Ang WXG; Wang WW; Chong HS; Tan SH; Cheong R; Chia JW; Syn NL; Shuen WH; Ba R; Kaliaperumal N; Au B; Hopkins R; Li X; Tan AC; Seet AOL; Connolly JE; Arkachaisri T; Chew V; Lajam ABM; Guo D; Chew MZW; Wasser M; Kumar P; Albani S; Toh HC
    Nat Commun; 2022 Oct; 13(1):6453. PubMed ID: 36307410
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Stat3 Tyrosine 705 and Serine 727 Phosphorylation Associate With Clinicopathological Characteristics and Distinct Tumor Cell Phenotypes in Triple-Negative breast cancer.
    Stenckova M; Nenutil R; Vojtesek B; Coates PJ
    Pathol Oncol Res; 2022; 28():1610592. PubMed ID: 36017196
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Glycosylated modification of muc1 maybe a new target to promote drug sensitivity and efficacy for breast cancer chemotherapy.
    Xi X; Wang J; Qin Y; Huang W; You Y; Zhan J
    Cell Death Dis; 2022 Aug; 13(8):708. PubMed ID: 35970845
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Antitumor efficacy of muc1-derived variable epitope library treatments in a mouse model of breast cancer.
    Odales J; Servín-Blanco R; Martínez-Cortés F; Guzman Valle J; Domínguez-Romero AN; Gevorkian G; Manoutcharian K
    Vaccine; 2022 Aug; 40(33):4796-4805. PubMed ID: 35788294
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinicopathological characteristics and prognosis of microinvasive breast cancer: A population-based analysis.
    Xu H; Han Y; Wu Y; Wang Y; Wang J; Xu B
    Cancer Med; 2022 Dec; 11(23):4501-4512. PubMed ID: 35598300
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Aggressive uveal melanoma displays a high degree of centrosome amplification, opening the door to therapeutic intervention.
    Sabat-Pośpiech D; Fabian-Kolpanowicz K; Kalirai H; Kipling N; Coupland SE; Coulson JM; Fielding AB
    J Pathol Clin Res; 2022 Jul; 8(4):383-394. PubMed ID: 35474453
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. muc1 triggers lineage plasticity of Her2 positive mammary tumors.
    Pang Z; Dong X; Deng H; Wang C; Liao X; Liao C; Liao Y; Tian W; Cheng J; Chen G; Yi H; Huang L
    Oncogene; 2022 May; 41(22):3064-3078. PubMed ID: 35461328
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Predictive value of EGFR mutation in non-small-cell lung cancer patients treated with platinum doublet postoperative chemotherapy.
    Takahashi T; Sakai K; Kenmotsu H; Yoh K; Daga H; Ohira T; Ueno T; Aoki T; Hayashi H; Yamazaki K; Hosomi Y; Chen-Yoshikawa TF; Okumura N; Takiguchi Y; Sekine A; Haruki T; Yamamoto H; Sato Y; Akamatsu H; Seto T; Saeki S; Sugio K; Nishio M; Inokawa H; Yamamoto N; Nishio K; Tsuboi M
    Cancer Sci; 2022 Jan; 113(1):287-296. PubMed ID: 34689382
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Plasma Mucin-1 (CA15-3) Levels in Autosomal Dominant Tubulointerstitial Kidney Disease due to muc1 Mutations.
    Vylet'al P; Kidd K; Ainsworth HC; Springer D; Vrbacká A; Přistoupilová A; Hughey RP; Alper SL; Lennon N; Harrison S; Harden M; Robins V; Taylor A; Martin L; Howard K; Bitar I; Langefeld CD; Barešová V; Hartmannová H; Hodaňová K; Zima T; Živná M; Kmoch S; Bleyer AJ
    Am J Nephrol; 2021; 52(5):378-387. PubMed ID: 34098564
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [A pulmonary tumor that racks our brains!].
    Tauziède-Espariat A; Kleinmann P; Benali A; Bitton L; Antin G; Hasty L; Georges O
    Ann Pathol; 2021 Sep; 41(5):486-489. PubMed ID: 33926758
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Aptamer-Peptide Conjugates as Targeted Chemosensitizers for breast cancer Treatment.
    Tan Y; Li Y; Qu YX; Su Y; Peng Y; Zhao Z; Fu T; Wang XQ; Tan W
    ACS Appl Mater Interfaces; 2021 Mar; 13(8):9436-9444. PubMed ID: 33306339
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Associations between the expression of mucins (muc1, MUC2, MUC5AC and MUC6) and clinicopathologic parameters of human breast carcinomas.
    Oral O; Unverdi H; Kumcu E; Turkbey D; Dogan S; Hucumenoglu S
    Indian J Pathol Microbiol; 2020; 63(4):551-558. PubMed ID: 33154304
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. cancer-associated hypersialylated muc1 drives the differentiation of human monocytes into macrophages with a pathogenic phenotype.
    Beatson R; Graham R; Grundland Freile F; Cozzetto D; Kannambath S; Pfeifer E; Woodman N; Owen J; Nuamah R; Mandel U; Pinder S; Gillett C; Noll T; Bouybayoune I; Taylor-Papadimitriou J; Burchell JM
    Commun Biol; 2020 Nov; 3(1):644. PubMed ID: 33149188
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Dual-Probe Approach for Mass Spectrometric Quantification of muc1-Specific Terminal Gal/GalNAc
    Sun B; Xu F; Zhang Y; Hu Y; Chen Y
    Anal Chem; 2020 Jun; 92(12):8340-8349. PubMed ID: 32502344
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Signet Ring Cell Differentiation in Salivary Duct Carcinoma with Rhabdoid Features: Report of Three Cases and Literature Review.
    Akaki M; Ishihara A; Nagai K; Naono H; Taguchi K; Yamamoto H; Tanaka H; Kataoka H
    Head Neck Pathol; 2021 Mar; 15(1):341-351. PubMed ID: 32488734
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.